Led by ANZGOG co-founder Professor Michael Friedlander AM, PARAGON was one of ANZGOG's first practice-changing studies. The publications arising from the insights and data collected because of this pivotal trial continue to contribute to research on [...]
ANZGOG congratulates Members Dr Paul Cohen and Prof Kum Kum Khanna for their success in the Fund for New Research Grant round 2021. Dr Cohen will be granted $100K for his clinical concept - 'STRatIfication [...]
Assoc Prof Philip Beale ANZGOG Chair As we meet the end of yet another challenging year, I feel that now is the perfect time to reflect on our achievements this year as an organisation. [...]
A new journal has been published by the National Library of Medicine for ANZGOG's MOST-S26 study. The Measure of Ovarian Symptoms and Treatment study (MOST-S26) detected an improvement in symptoms of peripheral neuropathy, psychological [...]
Professor Penny Webb gives insight into the new British Journal of Cancer publication for an ovarian cancer study. The study looked at the use of a statin to improve survival for women with ovarian cancer. [...]
Dr Viet Do is an experienced clinical researcher in the gynaecological cancer space. As an ANZGOG member and Director of Radiation Oncology at SWSLHD at Liverpool and Campbelltown Hospitals, Dr Do is passionate about educating future [...]
WHAM (What Happens After Menopause?) was a multicentre prospective study investigating the impact of risk reducing bilateral salpingo-oophorectomy on non-cancer outcomes in young high-risk women. The ANZGOG supported study assessed the relationship between surgical menopause and [...]
A new journal has been published by the Journal for ImmunoTherapy of Cancer for ANZGOG's PHAEDRA study. The PHAEDRA study examined the activity of the immunotherapeutic agent durvalumab in women with advanced endometrial cancer that [...]
A significant international study in cervical cancer treatment, the ANZGOG-led OUTBACK trial will be presented at the 2021 ASCO Annual Meeting Plenary Session to reveal its highly anticipated results. OUTBACK is an academic collaboration [...]
With over a decade of experience, Gel Bolanos began nursing in the Philippines, has worked in clinical research, spent the last six years as a Research Nurse/Study Coordinator, and is currently a Study Coordinator at the [...]
Australia New Zealand Gynaecological Oncology Group www.anzgog.org.au
Level 6, Lifehouse, 119-143 Missenden Road Camperdown NSW 2050 T:+61 2 8071 4880
E: contact@anzgog.org.au © 2024 ANZGOG | Copyright | Disclaimer | ANZGOG Policies | Whistleblower
Virtually every advance in cancer survival has been made on the back of clinical trials.
As the peak, national gynaecological cancer clinical trials organisation for Australia and New Zealand, ANZGOG‘s purpose is to improve outcomes and quality of life for women with gynaecological cancer by conducting research.
We conduct and promote clinical trials and undertake multidisciplinary research into the causes, prevention and treatments of gynaecological cancers.
Research Community Volunteers will have the opportunity to contribute to ANZGOG research at every stage of the development process.
Community volunteers will lend their voices to research discussions sharing their personal perspective and representing the broader views of people with lived experience of gynaecological cancer.
Opportunities range from sharing your lived experience as a participant on a research grant working party or a Trial Management Committee, through to Research Advisor and Expert roles requiring additional levels of education and expertise in research analysis.
Gynaecological cancer research is critically needed but critically underfunded. WomenCan is the fundraising arm of ANZGOG, supporting ANZGOG by funding our programs to improve life for women with gynaecological cancer.
WomenCan’s mission is to engage the community to fund pioneering discoveries that will enable women with a gynaecological cancer to live better and live longer.
WomenCan believes the power of the collective, united in a common purpose, can make a real difference in the lives of women with gynaecological cancers.
ANZGOG’s Survivors Teaching Students (STS) Program is a ground-breaking volunteer program that brings gynaecological cancer survivors and caregivers into the classrooms of health professional students to teach them about women’s experiences with the diseases.
Survivors and caregivers are in a unique position to help students understand the ‘lived experience’ of a gynaecological cancer, including the psychosocial impact, and the importance of timely diagnosis, good health communication and compassionate care.
By joining STS and sharing your story, you will have the opportunity to impact the future care of women diagnosed with a gynaecological cancer, with participating students reporting not only increased understanding of gynaecological cancers but also a deeper understanding of the patient experience to take forward into their practice.
Since the program began at ANZGOG in 2017, our volunteers have shared their stories with more than 11,000 students across Australia and New Zealand.
